|
Volumn 92, Issue 4, 2012, Pages 425-427
|
Clinical translation of cell-based pharmacogenomic discovery
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYTARABINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CELL GROWTH;
CELL THERAPY;
CLINICAL TRIAL (TOPIC);
CYTOTOXICITY;
GENE EXPRESSION;
GENE FREQUENCY;
GENETIC ASSOCIATION;
GENETIC VARIABILITY;
GERM LINE GENE THERAPY;
HUMAN;
IN VITRO STUDY;
LOSS OF FUNCTION MUTATION;
LUNG NON SMALL CELL CANCER;
LUNG SMALL CELL CANCER;
LYMPHOBLASTOID CELL LINE;
NONHUMAN;
OVARY CANCER;
OVERALL SURVIVAL;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SINGLE NUCLEOTIDE POLYMORPHISM;
TREATMENT RESPONSE;
ANIMALS;
CELL LINE, TUMOR;
DRUG DISCOVERY;
GENOMICS;
HUMANS;
PHARMACOGENETICS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
TRANSLATIONAL MEDICAL RESEARCH;
|
EID: 84866617047
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2012.115 Document Type: Article |
Times cited : (19)
|
References (4)
|